Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

White Sands Pharma

2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
$4.3M LATEST DEAL AMOUNT
Description

Developer of novel treatments for Irritable Bowel Syndrome.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Healthcare Services
Primary Office
  • 401 South Cedar Street
  • Little Rock, AR 72205
  • United States

+1 (941) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore White Sands Pharma’s full profile, request a free trial.

White Sands Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 01-Mar-2018 $4.3M 00.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

White Sands Pharma Executive Team (1)

Name Title Board
Seat
Contact
Info
Michael Geranen Chief Executive Officer & Manager